Matthew Buten

Insider Reports History

Entity
Individual
Location
215 Church Street, New Haven, CT
Signature
/s/ George Clark, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Buten:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Biohaven Ltd. Chief Financial Officer Common Shares 189K $4.17M $22.00 Oct 5, 2023 Direct
Biohaven Ltd. Chief Financial Officer Stock Options (Right to buy) 96.3K Jan 2, 2024 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Common Shares 0 $148.50 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Restricted Share Unit Award 0 Oct 3, 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Chief Financial Officer Stock Options (Right to Buy) 0 Oct 3, 2022 Direct

Insider Reports Filed by Matthew Buten

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BHVN Biohaven Ltd. Jan 2, 2024 1 $0 4 Jan 4, 2024 Chief Financial Officer
BHVN Biohaven Ltd. Nov 2, 2023 1 $0 4 Nov 6, 2023 Chief Financial Officer
BHVN Biohaven Ltd. Oct 5, 2023 1 $500K 4 Oct 6, 2023 Chief Financial Officer
BHVN Biohaven Ltd. Oct 25, 2022 1 $1.5M 4 Oct 26, 2022 Chief Financial Officer
BHVN Biohaven Ltd. Oct 3, 2022 10 -$5 4 Oct 5, 2022 Chief Financial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Oct 3, 2022 4 -$917K 4 Oct 3, 2022 Chief Financial Officer
BHVN Biohaven Ltd. Sep 22, 2022 0 $0 3 Sep 28, 2022 Treasurer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Jan 7, 2022 1 $0 4 Jan 7, 2022 Chief Financial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 31, 2021 3 -$871K 4 Jan 4, 2022 Chief Financial Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 8, 2021 1 $0 4 Dec 14, 2021 Officer
BHVN Biohaven Pharmaceutical Holding Co Ltd. Dec 8, 2021 0 $0 3 Dec 14, 2021 Officer